Compound improves stroke outcome by reducing lingering inflammation
![](https://familymednews.com/wp-content/uploads/sites/15/2018/04/compoundimpr-900x280.jpg)
An experimental compound appears to improve stroke outcome by reducing the destructive inflammation that can continue months after a stroke, scientists report. Rats consuming compound 21 following a clot-based stroke – the most common type in humans – don’t have a smaller stroke size but do have better memory and movement in its aftermath, says Dr. Adviye Ergul, vascular physiologist […]
Continue reading »